Get started

Compare · ALPA vs DXCM

ALPA vs DXCM

Side-by-side comparison of Alpha Healthcare Acquisition Corp. III (ALPA) and DexCom Inc. (DXCM): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both ALPA and DXCM operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
  • DXCM carries a market cap of $29.97B.
  • DXCM has hit the wire 14 times in the past 4 weeks while ALPA has been quiet.
  • DXCM has more recent analyst coverage (25 ratings vs 0 for ALPA).
MetricALPADXCM
Company
Alpha Healthcare Acquisition Corp. III
DexCom Inc.
Price
-
-
Market cap
-
$29.97B
1M return
-
-5.54%
1Y return
-
+34.83%
Sector
Health Care
Health Care
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Exchange
NASDAQ
NASDAQ
IPO
2021
2005
News (4w)
0
14
Recent ratings
0
25
ALPA

Alpha Healthcare Acquisition Corp. III

Alpha Healthcare Acquisition Corp. III focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in New York, New York.

DXCM

DexCom Inc.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom G7, a next generation G7 CGM system; and Dexcom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.

Latest ALPA

Latest DXCM